Ascend Advanced Therapies is a startup based in the United States, 1 tracked investor.
Ascend Advanced Therapies is a company founded in 2023 headquartered in the United States. Brouky records 1 investor associated with the company.
Ascend Advanced Therapies provides flexible chemistry, manufacturing, and controls (CMC) services for gene therapy companies, focusing initially on Adeno-associated virus (AAV) vectors to support production capacity and reduce costs.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.